Clinical TrialsSearch results
Number of results: 395
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Z-206 Phase III Clinical Trial -Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phase-
- Patients with Crohn's disease in remission phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-12-22
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phase -
- Patients with ulcerative colitis in remission phase.
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phase -
- Patients with ulcerative colitis in active phase
- Zeria Pharmaceutical Co.,LTD.
- 2005-11-21
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- Phase III Clinical Study on Taste Disorder by Z-103 -Double Blind Comparison Study on Patients with Zinc-Deficient and Idiopathic Taste Disorders -
- Zinc-Deficient and Idiopathic Taste Disorders
- ZERIA Pharmaceutical Co.,Ltd.
- 2006-04-10
Other
- Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection
- Gastric ulcer with Helicobacter pylori infection
- Zeria Pharmaceutical Co.,LTD.
- 2005-09-13
Other
- Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phase -
- Patients with Crohn's disease in active phase
- Zeria Pharmaceutical Co.,LTD
- 2005-12-22
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Recruiting
- A clinical study of non-invasive diagnostic criteria for detrusor underactivity
- UAB syndrome
- Yoshida Masaki
- 2023-04-30